Pure Bioscience (PURE) 0.7400 $PURE
PURE Resubmits Food Contact Notification to FDA for SDC Antimicrobial Use in Raw Poultry Processing
Marketwired - Wed Jun 17, 7:41AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it has resubmitted a Food Contact Notification (FCN) to the US Food and Drug Administration (FDA) for Silver Dihydrogen Citrate (SDC) as an online reprocessing (OLR) antimicrobial for raw poultry processing.
Pure Bioscience's (PURE) CEO Hank Lambert Discusses Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jun 11, 9:46PM CDT
PURE Bioscience reports FQ3 results
Seeking Alpha - at Seeking Alpha - Thu Jun 11, 3:06PM CDT
PURE Bioscience Reports 2015 Fiscal Third Quarter and Nine-Month Financial Results
Marketwired - Thu Jun 11, 3:02PM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal three and nine-month periods ended April 30, 2015.
PURE Bioscience to Present at the 2015 Impact Investor Conference on June 19th
Marketwired - Wed Jun 10, 7:36AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the 2015 Impact Investor Conference hosted by The Brewer Group Companies, GWG Holdings, Inc., and Greentree Financial Group on Friday, June 19, 2015 at the Minneapolis Club in Minneapolis, MN.
GWGH: 8.75 (unch)
PURE Bioscience Hosts Fiscal Q3 Results Conference Call June 11, 2015 to Review Progress of SDC-Based Food Safety Solutions Strategy
Marketwired - Thu Jun 04, 7:36AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that the Company will host an investor conference call on Thursday, June 11, 2015 at 1:30pm PDT (4:30pm EDT).
PURE Bioscience Prepares to Resubmit Food Contact Notification With FDA for SDC Antimicrobial Use in Raw Poultry Processing
Marketwired - Wed Jun 03, 3:03PM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that as a result of recent discussions with the FDA, PURE intends to resubmit its Food Contact Notification (FCN) for use of its SDC antimicrobial in raw poultry processing before the end of June.
PURE Bioscience to Present at the 2015 Marcum MicroCap Conference on May 28th
Marketwired - Mon May 18, 7:41AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the 2015 Marcum MicroCap Conference on Thursday, May 28, 2015 in New York City at the Grand Hyatt Hotel.
PURE Bioscience to Present at the 2nd Annual Growth Capital Expo on April 13th
Marketwired - Thu Apr 09, 3:03PM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the 2nd Growth Capital Expo being held on April 12-14, 2015 at Caesars Palace in Las Vegas, NV.
PURE Bioscience's (PURE) CEO Hank Lambert on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Mar 04, 9:01PM CST
PURE Bioscience and Intercon Chemical Present PURE(R) Hard Surface Disinfectant to Cruise Lines International Association's Gastrointestinal Illness Technology Conference
Marketwired - Wed Feb 18, 7:42AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, and Intercon Chemical Company, the exclusively licensed manufacturer of SDC-based products, announced today the two companies made a "by invitation only" joint scientific presentation to the attendees of the Cruise Lines International Association's (CLIA) GI Illness Technology Conference in Geneva, Switzerland. Attendees of the technology conference were GI Illness task force representatives (including Infectious Disease Control Managers and Medical Directors) of the top 10 cruise lines, including Carnival Corporation, Royal Caribbean Cruises, Norwegian Cruise Lines and MSC Cruises. The invitation to present was a direct result of Intercon's sales and industry education efforts.
RCL: 83.59 (-0.03), CCL: 51.84 (-0.36)
PURE Bioscience Signs Agreement With All American Chemical Company to Distribute PURE(R) Hard Surface Disinfectant
Marketwired - Thu Feb 05, 7:41AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it has signed a non-exclusive agreement with All American Chemical Company Inc. to distribute PURE(R) Hard Surface disinfectant to its network of more than 175+ food and beverage manufacturers/processors. The arrangement broadens and deepens the sales reach for PURE's powerful antimicrobial products.
PURE Bioscience Expands National Sales Rollout for PURE(R) Hard Surface Disinfectant at SUBWAY(R) Restaurants' Multi Unit Owners Conference
Marketwired - Mon Feb 02, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it broadened its SUBWAY(R) Restaurants* sales and marketing initiative as an invited preferred vendor presenter at the January 2015 SUBWAY(R) Winter Meeting of Multi Unit Owners in Miami, Florida.
PURE Bioscience Reports Fiscal First Quarter 2015 Financial Results
Marketwired - Thu Dec 11, 3:02PM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2014 (Fiscal Q1 2015).
PURE(R) Hard Surface Disinfectant Remediates Listeria Contamination in Shuttered Food Processing Facility
Marketwired - Wed Dec 10, 7:34AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that Dr. James L. Marsden, Ph.D., Distinguished Professor-Food Safety and Security Kansas State University, has released a White Paper (click-here) which details the successful remediation of Listeria contamination in a food processing facility. The decontamination of the plant was achieved by utilizing a cleaning and sanitizing program incorporating PURE(R) Hard Surface disinfectant.
PURE Bioscience to Host Fiscal Q1 Investor Conference Call Thursday, December 11, 2014
Marketwired - Tue Dec 02, 7:34AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that the Company will host an investor conference call on Thursday, December 11, 2014 at 1:30pm PST (4:30pm EST).
PURE Bioscience Updates Ongoing Sales Path for EPA Approved PURE(R) Hard Surface Disinfectant With SUBWAY(R) Restaurants and Others
Marketwired - Wed Nov 12, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today provided an update on its sales path to commercialize PURE(R) Hard Surface as a superior disinfectant for food contact surfaces in restaurant chains and food processors/manufacturers.
PURE Withdraws Food Contact Notification for SDC Antimicrobial Use in Raw Poultry Processing
Marketwired - Mon Nov 10, 7:35AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it has withdrawn the Food Contact Notification (FCN) it submitted to the U.S. Food and Drug Administration (FDA) in July 2014 for the use of SDC in raw poultry processing. PURE had submitted the FCN based on test results demonstrating that the SDC use provided a material significant reduction in Salmonella contamination in raw poultry.
Pure Bioscience withdraws antimicrobial FCN
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 7:25AM CST
PURE Resubmits Food Contact Notification to FDA for SDC Antimicrobial Use in Raw Poultry Processing
Marketwired - Wed Jun 17, 7:41AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it has resubmitted a Food Contact Notification (FCN) to the US Food and Drug Administration (FDA) for Silver Dihydrogen Citrate (SDC) as an online reprocessing (OLR) antimicrobial for raw poultry processing.
Pure Bioscience's (PURE) CEO Hank Lambert Discusses Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jun 11, 9:46PM CDT
PURE Bioscience reports FQ3 results
Seeking Alpha - at Seeking Alpha - Thu Jun 11, 3:06PM CDT
PURE Bioscience Reports 2015 Fiscal Third Quarter and Nine-Month Financial Results
Marketwired - Thu Jun 11, 3:02PM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal three and nine-month periods ended April 30, 2015.
PURE Bioscience to Present at the 2015 Impact Investor Conference on June 19th
Marketwired - Wed Jun 10, 7:36AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the 2015 Impact Investor Conference hosted by The Brewer Group Companies, GWG Holdings, Inc., and Greentree Financial Group on Friday, June 19, 2015 at the Minneapolis Club in Minneapolis, MN.
GWGH: 8.75 (unch)
PURE Bioscience Hosts Fiscal Q3 Results Conference Call June 11, 2015 to Review Progress of SDC-Based Food Safety Solutions Strategy
Marketwired - Thu Jun 04, 7:36AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that the Company will host an investor conference call on Thursday, June 11, 2015 at 1:30pm PDT (4:30pm EDT).
PURE Bioscience Prepares to Resubmit Food Contact Notification With FDA for SDC Antimicrobial Use in Raw Poultry Processing
Marketwired - Wed Jun 03, 3:03PM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that as a result of recent discussions with the FDA, PURE intends to resubmit its Food Contact Notification (FCN) for use of its SDC antimicrobial in raw poultry processing before the end of June.
PURE Bioscience to Present at the 2015 Marcum MicroCap Conference on May 28th
Marketwired - Mon May 18, 7:41AM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the 2015 Marcum MicroCap Conference on Thursday, May 28, 2015 in New York City at the Grand Hyatt Hotel.
PURE Bioscience to Present at the 2nd Annual Growth Capital Expo on April 13th
Marketwired - Thu Apr 09, 3:03PM CDT
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today the Company will present at the 2nd Growth Capital Expo being held on April 12-14, 2015 at Caesars Palace in Las Vegas, NV.
PURE Bioscience's (PURE) CEO Hank Lambert on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Mar 04, 9:01PM CST
PURE Bioscience and Intercon Chemical Present PURE(R) Hard Surface Disinfectant to Cruise Lines International Association's Gastrointestinal Illness Technology Conference
Marketwired - Wed Feb 18, 7:42AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, and Intercon Chemical Company, the exclusively licensed manufacturer of SDC-based products, announced today the two companies made a "by invitation only" joint scientific presentation to the attendees of the Cruise Lines International Association's (CLIA) GI Illness Technology Conference in Geneva, Switzerland. Attendees of the technology conference were GI Illness task force representatives (including Infectious Disease Control Managers and Medical Directors) of the top 10 cruise lines, including Carnival Corporation, Royal Caribbean Cruises, Norwegian Cruise Lines and MSC Cruises. The invitation to present was a direct result of Intercon's sales and industry education efforts.
RCL: 83.59 (-0.03), CCL: 51.84 (-0.36)
PURE Bioscience Signs Agreement With All American Chemical Company to Distribute PURE(R) Hard Surface Disinfectant
Marketwired - Thu Feb 05, 7:41AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it has signed a non-exclusive agreement with All American Chemical Company Inc. to distribute PURE(R) Hard Surface disinfectant to its network of more than 175+ food and beverage manufacturers/processors. The arrangement broadens and deepens the sales reach for PURE's powerful antimicrobial products.
PURE Bioscience Expands National Sales Rollout for PURE(R) Hard Surface Disinfectant at SUBWAY(R) Restaurants' Multi Unit Owners Conference
Marketwired - Mon Feb 02, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it broadened its SUBWAY(R) Restaurants* sales and marketing initiative as an invited preferred vendor presenter at the January 2015 SUBWAY(R) Winter Meeting of Multi Unit Owners in Miami, Florida.
PURE Bioscience Reports Fiscal First Quarter 2015 Financial Results
Marketwired - Thu Dec 11, 3:02PM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2014 (Fiscal Q1 2015).
PURE(R) Hard Surface Disinfectant Remediates Listeria Contamination in Shuttered Food Processing Facility
Marketwired - Wed Dec 10, 7:34AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that Dr. James L. Marsden, Ph.D., Distinguished Professor-Food Safety and Security Kansas State University, has released a White Paper (click-here) which details the successful remediation of Listeria contamination in a food processing facility. The decontamination of the plant was achieved by utilizing a cleaning and sanitizing program incorporating PURE(R) Hard Surface disinfectant.
PURE Bioscience to Host Fiscal Q1 Investor Conference Call Thursday, December 11, 2014
Marketwired - Tue Dec 02, 7:34AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that the Company will host an investor conference call on Thursday, December 11, 2014 at 1:30pm PST (4:30pm EST).
PURE Bioscience Updates Ongoing Sales Path for EPA Approved PURE(R) Hard Surface Disinfectant With SUBWAY(R) Restaurants and Others
Marketwired - Wed Nov 12, 7:36AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today provided an update on its sales path to commercialize PURE(R) Hard Surface as a superior disinfectant for food contact surfaces in restaurant chains and food processors/manufacturers.
PURE Withdraws Food Contact Notification for SDC Antimicrobial Use in Raw Poultry Processing
Marketwired - Mon Nov 10, 7:35AM CST
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it has withdrawn the Food Contact Notification (FCN) it submitted to the U.S. Food and Drug Administration (FDA) in July 2014 for the use of SDC in raw poultry processing. PURE had submitted the FCN based on test results demonstrating that the SDC use provided a material significant reduction in Salmonella contamination in raw poultry.
Pure Bioscience withdraws antimicrobial FCN
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 7:25AM CST
